Your browser doesn't support javascript.
loading
KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.
Nozawa, Yuichi; Umemura, Takeji; Joshita, Satoru; Katsuyama, Yoshihiko; Shibata, Soichiro; Kimura, Takefumi; Morita, Susumu; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji; Ota, Masao.
Afiliação
  • Nozawa Y; Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Umemura T; Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Joshita S; Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Katsuyama Y; Department of Pharmacy, Shinshu University Hospital, Matsumoto, Japan.
  • Shibata S; Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Kimura T; Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Morita S; Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Komatsu M; Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Matsumoto A; Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Tanaka E; Division of Hepatology and Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Ota M; Department of Legal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
PLoS One ; 8(12): e83381, 2013.
Article em En | MEDLINE | ID: mdl-24349500

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Interleucinas / Interferon-alfa / Hepatite C Crônica / Receptores KIR / Antígenos HLA Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Interleucinas / Interferon-alfa / Hepatite C Crônica / Receptores KIR / Antígenos HLA Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2013 Tipo de documento: Article